Gilvetmab is the first and only immune checkpoint inhibitor developed for the treatment of mast cell tumors (MCTs) and melanomas in dogs.
LEARN MOREFor the prevention and treatment of Selenium-Tocopherol Deficiency (white muscle disease) syndrome in calves.
LEARN MOREFirst and only non-adjuvanted feline leukemia virus (FeLV) vaccine built on RNA particle technology
LEARN MOREFirst and only canine flu vaccine built on RNA particle technology
LEARN MOREFor induction of estrus in prepuberal gilts and healthy weaned sows experiencing delayed return to estrus.
LEARN MORE